MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 71 filers reported holding MERSANA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $63,367 | -55.1% | 31,526 | 0.0% | 0.00% | – |
| Q1 2024 | $141,236 | -8.5% | 31,526 | -74.1% | 0.00% | – |
| Q3 2023 | $154,308 | +75.3% | 121,502 | +467.4% | 0.00% | – |
| Q1 2023 | $88,016 | -64.1% | 21,415 | -65.2% | 0.00% | -100.0% |
| Q1 2022 | $245,000 | -36.2% | 61,525 | -0.3% | 0.00% | 0.0% |
| Q4 2021 | $384,000 | +72.2% | 61,715 | +161.0% | 0.00% | 0.0% |
| Q3 2021 | $223,000 | +8.3% | 23,650 | +55.6% | 0.00% | 0.0% |
| Q2 2021 | $206,000 | +758.3% | 15,200 | -0.2% | 0.00% | – |
| Q3 2019 | $24,000 | -55.6% | 15,230 | +13.8% | 0.00% | – |
| Q2 2019 | $54,000 | – | 13,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $28,503,484 | 2.94% |
| Logos Global Management LP | 2,800,000 | $9,212,000 | 1.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,100,000 | $3,619,000 | 1.12% |
| 5AM Venture Management, LLC | 1,305,000 | $4,293,450 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $3,290,000 | 1.02% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $2,975,042 | 0.93% |
| Sarissa Capital Management LP | 2,632,900 | $8,662,241 | 0.86% |
| DAFNA Capital Management LLC | 810,845 | $2,667,680 | 0.73% |
| Tri Locum Partners LP | 428,307 | $1,409,130 | 0.52% |
| Avidity Partners Management LP | 3,790,000 | $12,469,100 | 0.44% |